Modified release tablet formulations with enhanced...

Details Modified release tablet formulations with enhanced... Modified release tablet formulations with enhanced...

A - Human Necessities

61

K

A61K 9/20 (2006.01)

Patent

CA 2616845

A method of formulating a drug in solid dosage form of a specified hardness, the drug containing at least one pharmaceutically active agent that has a pH dependent release profile, at least one non-pH dependent sustained release agent, and an effective amount of Eudragit L100-55.

L'invention concerne un procédé de préparation d'un médicament sous forme posologique solide présentant une dureté spécifiée, ce médicament contenant au moins un agent pharmaceutiquement actif présentant un profil de libération dépendant du pH, au moins un agent à libération prolongée non dépendante du pH, et une dose efficace d'Eudragit L100-55.

Affiliated with

Also associated with

Rating

Modified release tablet formulations with enhanced... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified release tablet formulations with enhanced..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified release tablet formulations with enhanced... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1999154